Skip to content
November 30, 2022

Equity.Guru

Investment information for the new generation

Gaalen Engen

Fortune Bay (FOR.V), a Canadian-based gold and uranium explorer operating in Canada’s top-ranked jurisdiction, filed an NI 43-101 PEA Technical Report for the Goldfields Gold Project in Saskatchewan. The…
Newrange Gold (NRG.V), a Canadian gold junior focused on district-scale exploration for precious metals in the prolific Red Lake District of northwestern Ontario, announced today that it and Great…
Predictmedix (PMED.C), a Canadian-based provider of rapid health screening solutions, announced today that it had deployed Safe Entry to be installed at LongArm Engineering’s Odessa Texas facility. LongArm’s facility…
Reklaim (MYID.V), a Toronto, Ontario-based company focused on providing compliant consumer data to brands, platforms and data companies, released financial results today for Q3 2022. The company reported strong…
Alamos Gold (AGI.T), a Canadian-based intermediate gold producer operating in North America, announced today that it extended high-grade gold mineralization beyond mineral reserves and resources at Puerto Del Aire…
GreenPower Motor Company (GPV.V), a Canadian electric bus manufacturer servicing the public transit, student transportation, passenger transportation and commercial cargo transport markets, released financial results from its Q2 2023,…
Base Carbon (BCBN.NEO), a Canadian-based company focused on providing capital, development expertise and management operating resources to projects involved primarily in voluntary carbon markets and the ESG economy, released…
NioCorp Developments (NB.T), a Canadian mineral explorer focused on bringing its world-class Elk Creek niobium project to production, announced today that Nebraska’s Governor-elect Jim Pillen (R) will be attending…
X1 Entertainment Group (XONE.C), a diversified Canadian portfolio company focused on acquiring assets across the gaming, esports, media and entertainment industries, announced today that it had launched a Rocket…
Marvel Biosciences (MRVL.V), a Canadian life sciences company focused on the discovery and development of a synthetic derivative compound of know proven drugs, announced today that its wholly owned…